Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial

Harbans Singh,Babita Yadav,Amit K. Rai,Sumit Srivastava,AJV Saiprasad,Sophia Jameela,Richa Singhal,Sanuj Muralidharan,Rijin Mohan,Shikha Chaudhary,Rakesh Rana,Shruti Khanduri,Bhagwan S. Sharma,Bhogavalli Chandrasekhararao,Narayanam Srikanth,Kartar S. Dhiman

Complementary therapies in medicine（2023）

引用 1|浏览16

暂无评分

摘要

•RCT assessing the efficacy of Withania somnifera (WS) and Zingiber officinale (ZO) in mild and moderate COVID-19.•WS and ZO hasten clinical recovery in mild and moderate COVID-19.•No disease progression was observed after WS and ZO administration in mild and moderate COVID-19.•The combination of WS and ZO is safe for managing mild and moderate COVID-19.

查看译文

关键词

Ayurveda,Ashwagandha,COVID-19,SARS-CoV-2,Shunthi,Withania somnifera,Zingiber officinale

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要